The Pennsylvania Medical Marijuana Advisory Board voted Monday to recommend allowing dried leafy marijuana to be sold to patients.
The bipartisan advisory board voted to make the recommendation to sell “dry leaf or plant form for administration by vaporization,” according to PennLive.com.
The website reported that the advisory board featured a representative from the state police, a county district attorney, and several doctors. The advisory board voted 11-0 to forward the recommendation. One member did not vote.
The Associated Press said the recommendation will be forwarded to Pennsylvania Department of Health Secretary Dr. Rachel Levine for consideration.
The Pennsylvania medical marijuana law that was approved in 2016 currently allows people with 17 medical conditions, including cancer, PTSD and autism, to use medicines derived from marijuana. In the regulation current form, patients suffering from one of the qualifying conditions will be able to access marijuana processed pills, ointment, patch, and oil form products that will be for sale with orders from a doctor. Leafy marijuana material will not be sold at dispensaries.
Medical marijuana advocates have said that the dried leafy form is more affordable than other forms and can be more effective for certain ailments.